Jari Koistinaho was recruited to lead the Neuroscience Center from the University of Eastern Finland where he was Professor of Stem Cell Research and Professor of Pharmacology. He was trained as physician at University of Tampere and did his doctorate on aging there. His inaugural lecture is titled Understanding the human brain.
Koistinaho has worked abroad for over seven years in total at the US National Institute of Health, University of California San Francisco, Stanford University, Indiana and Purdue Universities, and Karolinska Institute. Koistinaho is also the founder of three spin-off companies: Cerebricon Ltd acquired by Charles River Discovery Research Services 2009; Medeia Therapeutics Ltd 2006, and Aranda Pharma Ltd 2015.